Disclosure 0001628280-26-056285-1

SEC FORM 4

—

Amneal Pharmaceuticals, Inc. (AMRX)

Acquisition (code A) of 6,381,734 shares; price not stated (see filing).

Reporting Person Patel Chirag K. · Officer Title President & Co-CEO · Transaction Code A

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001628280-26-056285 · filed 2026-08-12 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Amneal Pharmaceuticals, Inc. (AMRX)." Disclosed 2026-08-12. https://desqlong.com/cards/0001628280-26-056285-1 (retrieved 2026-09-26).